True Papillae and Squamous Features in Prostate Carcinoma Represent a Potential Diagnostic Pitfall: Report of 3 Patients

Poorly differentiated prostate adenocarcinoma may closely mimic high-grade urothelial carcinoma, particularly when presenting as a bladder or prostatic urethral mass without clinical history or prostate-specific antigen (PSA) data. We describe 3 patients who presented with hematuria and bladder lesions strongly resembling invasive urothelial carcinomas on limited transurethral resection of the bladder (TURB) specimens. All lesions demonstrated papillae lined by high-grade multilayered epithelium with marked nuclear pleomorphism and brisk mitotic activity, features rarely seen in prostate carcinomas and more characteristic of urothelial carcinomas. One tumor showed squamoid differentiation. All specimens showed muscularis propria invasion. Clinical history available at the time of the biopsy indicated a prior TURB for urothelial carcinoma in 1 patient and a known history of prostate cancer in another one. On immunohistochemistry, tumors expressed androgen receptor and NKX3.1, focally PSA and diffuse pankeratin staining, with negative keratin 7, keratin 20, keratin 5/6, and GATA3; residual urothelium exhibited p40/p63 staining. These findings confirmed high-grade prostate adenocarcinoma involving the bladder. Upon diagnosis, a history of prostate cancer under androgen ablation therapy was revealed for 1 of the patients and a PSA level of 70 ng/ml for another 1. This series highlights an underrecognized morphologic pattern of prostate cancer that could lead to an erroneous diagnosis, particularly in the absence of PSA testing, complete clinical history or comprehensive immunostaining. Accurate distinction of poorly differentiated prostate carcinoma from urothelial carcinoma requires correlation with prior diagnoses and a focused immunohistochemical panel, as misclassification carries significant therapeutic implications. Pathologists should maintain awareness of this uncommon mimic.

Authors

Institutions

Publication Details

Journal
International Journal of Surgical Pathology
Published
2026-03-31
DOI
https://doi.org/10.1177/10668969261436403
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

True Papillae and Squamous Features in Prostate Carcinoma Represent a Potential Diagnostic Pitfall: Report of 3 Patients

Ioanna Maria Grypari, Vasiliki Tzelepi, M Melachrinou, Olga Kouroukli et al.
International Journal of Surgical Pathology
Bladder and Urothelial Cancer Treatments
article

True Papillae and Squamous Features in Prostate Carcinoma Represent a Potential Diagnostic Pitfall: Report of 3 Patients

Ioanna Maria Grypari, Vasiliki Tzelepi, M Melachrinou, Olga Kouroukli, Angeliki Pomoni, Dimitra Ganetsou
article en

Abstract

Poorly differentiated prostate adenocarcinoma may closely mimic high-grade urothelial carcinoma, particularly when presenting as a bladder or prostatic urethral mass without clinical history or prostate-specific antigen (PSA) data. We describe 3 patients who presented with hematuria and bladder lesions strongly resembling invasive urothelial carcinomas on limited transurethral resection of the bladder (TURB) specimens. All lesions demonstrated papillae lined by high-grade multilayered epithelium with marked nuclear pleomorphism and brisk mitotic activity, features rarely seen in prostate carcinomas and more characteristic of urothelial carcinomas. One tumor showed squamoid differentiation. All specimens showed muscularis propria invasion. Clinical history available at the time of the biopsy indicated a prior TURB for urothelial carcinoma in 1 patient and a known history of prostate cancer in another one. On immunohistochemistry, tumors expressed androgen receptor and NKX3.1, focally PSA and diffuse pankeratin staining, with negative keratin 7, keratin 20, keratin 5/6, and GATA3; residual urothelium exhibited p40/p63 staining. These findings confirmed high-grade prostate adenocarcinoma involving the bladder. Upon diagnosis, a history of prostate cancer under androgen ablation therapy was revealed for 1 of the patients and a PSA level of 70 ng/ml for another 1. This series highlights an underrecognized morphologic pattern of prostate cancer that could lead to an erroneous diagnosis, particularly in the absence of PSA testing, complete clinical history or comprehensive immunostaining. Accurate distinction of poorly differentiated prostate carcinoma from urothelial carcinoma requires correlation with prior diagnoses and a focused immunohistochemical panel, as misclassification carries significant therapeutic implications. Pathologists should maintain awareness of this uncommon mimic.

International Journal of Surgical Pathology
University of Patras (GR), General University Hospital of Patras (GR), Evangelismos Hospital (GR)
Good health and well-being
Openalex Percentile: Top 24%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.